=+13. Crawford Pharmaceuticals has developed a new drug, Vaxidene. The target amount for a single dose of Vaxidene is 100 mg. Patients can receive as little as 98 mg or as much as 102 mg without experiencing any ill effects. Because of potential liability issues, Crawford has determined that it is